Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01797562 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
A NA study, sponsored by Allerderm.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT01797562 is a NA study that has completed, run by Allerderm. The registered enrollment target is 116 participants.
The verdict
NCT01797562, a NA study, has completed, sponsored by Allerderm.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
The objective of the study was to evaluate the diagnostic performance and safety of T.R.U.E. Test allergens in pediatric subjects aged 6-17 years old. In total, 11 allergens were evaluated; 7 new allergens on panels 2.2 and 3.2 and 4 previously approved allergens for which changes were made to dose and excipient.
Interventions
- DIAGNOSTIC_TEST Panels 1.3, 2.2 and 3.2 experimental allergens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2012-12-10 |
| Est. Completion | 2015-09-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01797562
The ClinicalTrials.gov registry entry for NCT01797562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allerderm, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Panels 1.3, 2.2 and 3.2 experimental allergens is the first listed.
NCT01797562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01797562 about?
NCT01797562 is a clinical study titled "Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents". The objective of the study was to evaluate the diagnostic performance and safety of T.R.U.E. Test allergens in pediatric subjects aged 6-17 years old. In total, 11 allergens were evaluated; 7 new allergens on panels 2.2 and 3.2 and 4 previously approved allergens for which changes were made to dose ...
What is the current status of trial NCT01797562?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2012-12-10. Estimated completion is 2015-09-08.
What interventions are being tested in trial NCT01797562?
The interventions under investigation include: Panels 1.3, 2.2 and 3.2 experimental allergens (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01797562?
This trial is sponsored by Allerderm, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.